StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Total Equity by Quarter

Total Equity ($M)

QuarterlyAnnual

Novartis Total Equity: $37,564M in Q3 2026, down 16.1% from a year earlier. That is the lowest of the 40 quarters on record here.

Latest, Q3 2026
37,564
Period ended Sep 30, 2026
Change on a year earlier
-16.1%
44,752 in Q3 2025
History
40 quarters
Since Q4 2014
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| Total equity | 37 564 | 46 549”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Equity ($M)Year on yearSource
Q3 2026Sep 30, 202637,564-16.1%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202641,946-0.3%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 202638,927+1.2%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q4 2025Dec 31, 202546,549+5.5%Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Q3 2025Sep 30, 202544,752+3.0%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202542,054+0.4%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 202538,452-3.3%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q4 2024Dec 31, 202444,126-5.6%Novartis 20-F (0001370368-25-000004, filed 2025-01-31) ↗
Q3 2024Sep 30, 202443,441+13.6%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202441,902-19.3%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 202439,756-23.8%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q4 2023Dec 31, 202346,750-21.3%Novartis 20-F (0001370368-24-000004, filed 2024-01-31) ↗
Q3 2023Sep 30, 202338,245-37.2%Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202351,931-17.6%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 202352,142-15.5%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q4 2022Dec 31, 202259,423-12.4%Novartis 20-F (0001370368-23-000006, filed 2023-02-01) ↗

Cite this data

StockData. (2026). Novartis Total Equity ($M), quarterly Q4 2014–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-equity-total

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.